Riskpilot← Back to searchSign inGet full accessENTOMOPHARM ApS
APSBankruptCVR 32070108Krakasvej 17Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 2009— employees
Revenue 2012
DKK 446K
EBITDA margin
-417.1%
Equity ratio
-115.7%
Financial strength
Net profit 2012
DKK -2,2M
| Revenue | DKK 446K | — |
| EBITDA | DKK -1,9M | — |
| Net profit | DKK -2,2M | — |
| Total assets | DKK 1,6M | — |
| Equity | DKK -1,9M | — |
| Employees | — | — |
Legal name
ENTOMOPHARM ApS
CVR number
32070108
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
23. februar 2009
Share capital
DKK 1.627.421
Employees
—
VAT registered
No
Audit selected
No
Last report
2012-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med bestyrelsesformanden eller af den samlede bestyrelse
Address
Krakasvej 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 |
|---|---|
| Revenue | 446 |
| Staff expenses | -2.307 |
| EBITDA | -1.861 |
| Depreciation & amort. | -102 |
| EBIT | -1.963 |
| Net financials | -215 |
| Profit before tax | -2.178 |
| Tax | 24 |
| Net profit | -2.202 |
| Item | 2012 |
|---|---|
| Total assets | 1.609 |
| Equity | -1.862 |
| Long-term debt | 3.278 |
| Short-term debt | 193 |
| Total debt | 3.471 |
EBITDA margin
-417.1%
This company
15.8%
Market median
-2740% vs market
20122012
Equity ratio
-115.7%
This company
38.2%
Market median
-403% vs market
20122012
Return on equity
-220243800.0%
This company
18.4%
Market median
-1196977274% vs market
20122012
Net profit margin
-493.6%
This company
8.1%
Market median
-6194% vs market
20122012
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122012
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
20122012
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PA Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
HK Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
B Founder | Founder | 2009 | — | — |
VI Management | Management | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2010 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENTOMOPHARM ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Aadal Nielsen | Chief Executive Officer | 0 companies |
| Henrik Kristian Moltke | Chief Executive Officer | 0 companies |
| BioCabris | Founder | 0 companies |
| Verner Ingolf Aadal Nielsen | Management | 0 companies |
| Karin Verland | Board of Directors | 0 companies |
| Gunnar Anderssons | Board of Directors | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Uffe Rolf Arlø | Board of Directors | 0 companies |
| Gustaf Iuel-Brockdorff | Board of Directors | 0 companies |
| Jesper Roested | Board of Directors | 0 companies |
| Klaus Bæk Simonsen | Board of Directors | 0 companies |
| Bent Benemann Bischoff | Chairman | 0 companies |